{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:12:53Z","timestamp":1791205973859,"version":"4.1.0"},"reference-count":190,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.bcmd.2013.06.005","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T08:46:43Z","timestamp":1374655603000},"page":"2-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["TNF-\u03b1 signaling in Fanconi anemia"],"prefix":"10.1016","volume":"52","author":[{"given":"Wei","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Erden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qishen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2013.06.005_bb0005","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00062752-200301000-00011","article-title":"Genetic basis of Fanconi anemia","volume":"10","author":"Bagby","year":"2003","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.40.1.1","article-title":"Fanconi anaemia","volume":"40","author":"Tischkowitz","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0015","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1101\/gad.1370505","article-title":"The Fanconi anemia\/BRCA pathway: new faces in the crowd","volume":"19","author":"Kennedy","year":"2000","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1097-2765(01)00172-1","article-title":"Positional cloning of a novel Fanconi anemia gene, FANCD2","volume":"7","author":"Timmers","year":"2001","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0025","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/356763a0","article-title":"Cloning of cDNAs for Fanconi's anaemia by functional complementation","volume":"356","author":"Strathdee","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0030","first-page":"320","article-title":"Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA","volume":"14","author":"Foe","year":"1986","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0035","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/3093","article-title":"The Fanconi anaemia group G gene FANCG is identical with XRCC9","volume":"2","author":"de Winter","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/71626","article-title":"The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM","volume":"24","author":"de Winter","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0045","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-9297(07)62959-0","article-title":"Isolation of a cDNA representing the Fanconi anemia complementation group E gene","volume":"67","author":"de Winter","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0050","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/303067","article-title":"Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A","volume":"67","author":"Joenje","year":"2000","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0055","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in Fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0060","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ng1241","article-title":"A novel ubiquitin ligase is deficient in Fanconi anemia","volume":"35","author":"Meetei","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0065","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ng1458","article-title":"X-linked inheritance of Fanconi anemia complementation group B","volume":"36","author":"Meetei","year":"2004","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/ng1626","article-title":"A human ortholog of archael DNA repair protein HEF is defective in Fanconi anemia complementation group M","volume":"37","author":"Meetei","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0075","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ng1624","article-title":"The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia","volume":"37","author":"Levran","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","article-title":"Fanconi anemia is associated with a defect in the BRCA2 partner PALB2","volume":"39","author":"Xia","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0085","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cell.2007.03.009","article-title":"Identification of the FANCI protein, a monoubiquitinated FANCD2 paralog required for DNA repair","volume":"129","author":"Smogorzewska","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0095","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a Fanconi anemia-like disorder","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0100","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat. Genet."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0105","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/carcin\/bgq210","article-title":"RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer","volume":"31","author":"Somyajit","year":"2010","journal-title":"Carcinogenesis"},{"issue":"16","key":"10.1016\/j.bcmd.2013.06.005_bb0110","doi-asserted-by":"crossref","first-page":"6492","DOI":"10.1073\/pnas.1018487108","article-title":"Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway","volume":"108","author":"Yamamoto","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ajhg.2013.04.002","article-title":"Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia","volume":"92","author":"Bogliolo","year":"2013","journal-title":"Am. J. Hum. Genet."},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2013.06.005_bb0120","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.mrfmmm.2008.11.004","article-title":"The genetic and molecular basis of Fanconi anemia","volume":"668","author":"de Winter","year":"2009","journal-title":"Mutat. Res."},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0125","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2003-08-2915","article-title":"Heterogeneity in Fanconi anemia: evidence for two new genetic subtypes","volume":"103","author":"Levitus","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0130","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1089\/ars.2008.2129","article-title":"Oxidative stress in Fanconi anemia hematopoiesis and disease progression","volume":"10","author":"Du","year":"2008","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0135","doi-asserted-by":"crossref","first-page":"349837","DOI":"10.1155\/2012\/349837","article-title":"Chromosomal aberrations associated with clonal evolution and leukemic transformation in Fanconi anemia: clinical and biological implications","volume":"2012","author":"Meyer","year":"2012","journal-title":"Anemia"},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1532\/IJH97.05108","article-title":"Molecular pathogenesis of Fanconi anemia","volume":"82","author":"Collins","year":"2005","journal-title":"Int. J. Hematol."},{"issue":"16","key":"10.1016\/j.bcmd.2013.06.005_bb0145","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1101\/gad.1128303","article-title":"The Fanconi road to cancer","volume":"17","author":"D'Andrea","year":"2003","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0150","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1172\/JCI117481","article-title":"Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector","volume":"94","author":"Walsh","year":"1994","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0155","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.molcel.2007.01.003","article-title":"Identification of FAAP24, a Fanconi anemia core complex protein that interacts with FANCM","volume":"25","author":"Ciccia","year":"2007","journal-title":"Mol. Cell"},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0160","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.4161\/cc.8.8.8204","article-title":"FANCM\u2013FAAP24 and HCLK2: roles in ATR signalling and the Fanconi anemia pathway","volume":"8","author":"Horej\u015d\u00ed","year":"2009","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0165","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.molcel.2008.10.014","article-title":"FANCM and FAAP24 function in ATR-mediated checkpoint signaling independently of the Fanconi anemia core complex","volume":"32","author":"Collis","year":"2008","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0170","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/emboj.2009.385","article-title":"ATR activation and replication fork restart are defective in FANCM-deficient cells","volume":"29","author":"Schwab","year":"2010","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0175","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/emboj.2009.371","article-title":"FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signaling","volume":"29","author":"Luke-Glaser","year":"2010","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0180","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.molcel.2010.01.036","article-title":"MHF1\u2013MHF2, a histone-fold-containing protein complex, participates in the Fanconi anemia pathway via FANCM","volume":"37","author":"Singh","year":"2010","journal-title":"Mol. Cell"},{"issue":"14","key":"10.1016\/j.bcmd.2013.06.005_bb0185","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2011-10-385963","article-title":"FAAP20: a novel ubiquitin-binding FA nuclear core-complex protein required for functional integrity of the FA\u2013BRCA DNA repair pathway","volume":"119","author":"Ali","year":"2012","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0190","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2008-04-152710","article-title":"HES1 is a novel interactor of the Fanconi anemia core complex","volume":"112","author":"Tremblay","year":"2008","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0195","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/sj.emboj.7601666","article-title":"FAAP100 is essential for activation of the Fanconi anemia-associated DNA damage response pathway","volume":"26","author":"Ling","year":"2007","journal-title":"EMBO J."},{"issue":"20","key":"10.1016\/j.bcmd.2013.06.005_bb0200","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in Fanconi's anemia and breast cancer","volume":"362","author":"D'Andrea","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-genet-102108-134222","article-title":"How the Fanconi anemia pathway guards the genome","volume":"43","author":"Moldovan","year":"2009","journal-title":"Annu. Rev. Genet."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0210","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ng0510-368","article-title":"Fanconi anemia and breast cancer susceptibility meet again","volume":"42","author":"Levy-Lahad","year":"2010","journal-title":"Nat. Genet."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0215","doi-asserted-by":"crossref","first-page":"e62017","DOI":"10.1371\/journal.pone.0062017","article-title":"A protein prioritization approach tailored for the FA\/BRCA pathway","volume":"8","author":"Haitjema","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0921-8777(98)00024-X","article-title":"Is Fanconi anemia caused by a defect in the processing of DNA damage?","volume":"408","author":"Buchwald","year":"1998","journal-title":"Mutat. Res."},{"issue":"10","key":"10.1016\/j.bcmd.2013.06.005_bb0225","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1182\/blood.V97.10.3017","article-title":"Functional correction of FA-C cells with FANCC suppresses the expression of interferon gamma-inducible genes","volume":"97","author":"Fagerlie","year":"2001","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0230","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1182\/blood-2002-07-2170","article-title":"A 20-year perspective on the International Fanconi Anemia Registry (IFAR)","volume":"101","author":"Kutler","year":"2003","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0235","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1038\/sj.leu.2401586","article-title":"Selective pressure as an essential force in molecular evolution of myeloid leukemic clones: a view from the window of Fanconi anemia","volume":"13","author":"Lensch","year":"1999","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0240","first-page":"168","article-title":"Gene transfer for the eventual treatment of Fanconi's anemia","volume":"35","author":"Liu","year":"1998","journal-title":"Semin. Hematol."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0245","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/ajh.2830420211","article-title":"Tumor necrosis factor-alpha overproduction in Fanconi's anemia","volume":"42","author":"Schultz","year":"1993","journal-title":"Am. J. Hematol."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0250","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood.V83.5.1216.1216","article-title":"Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alpha","volume":"83","author":"Rosselli","year":"1994","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0255","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-alpha and IFN-gamma are overexpressed in the bone marrow of Fanconi anemia patients and TNF-alpha suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"issue":"49","key":"10.1016\/j.bcmd.2013.06.005_bb0260","doi-asserted-by":"crossref","first-page":"50986","DOI":"10.1074\/jbc.M407160200","article-title":"A role for the Fanconi anemia C protein in maintaining the DNA damage-induced G2 checkpoint","volume":"279","author":"Freie","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0265","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1038\/sj.onc.1207116","article-title":"Control of apoptosis by p53","volume":"22","author":"Fridman","year":"2003","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0270","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/carcin\/23.1.67","article-title":"The FANCG Fanconi anemia protein interacts with CYP2E1: possible role in protection against oxidative DNA damage","volume":"23","author":"Futaki","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0275","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1101\/gad.12.19.2973","article-title":"The complexity of p53 modulation: emerging patterns from divergent signals","volume":"12","author":"Giaccia","year":"1998","journal-title":"Genes"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0280","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood.V85.8.1985.bloodjournal8581985","article-title":"Childhood monosomy 7: epidemiology, biology, and mechanistic implications","volume":"85","author":"Luna-Fineman","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0285","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1182\/blood.V78.11.2982.2982","article-title":"Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children: correlation between chromosomal abnormalities and prior therapy","volume":"78","author":"Rubin","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0290","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1182\/blood.V95.6.2093","article-title":"Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure","volume":"95","author":"West","year":"2000","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0295","doi-asserted-by":"crossref","first-page":"4558","DOI":"10.1182\/blood.V88.12.4558.bloodjournal88124558","article-title":"Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene","volume":"88","author":"Cumming","year":"1996","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0300","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/89937","article-title":"Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1","volume":"7","author":"Cumming","year":"2001","journal-title":"Nat. Med."},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0305","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1182\/blood.V91.11.4092","article-title":"Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac\u2212\/\u2212 mice","volume":"91","author":"Haneline","year":"1998","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0310","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1182\/blood.V94.1.1.413k03_1_8","article-title":"Loss of FancC function results in decreased hematopoietic stem cell repopulating ability","volume":"94","author":"Haneline","year":"1999","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0315","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1182\/blood-2002-08-2404","article-title":"Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc\u2212\/\u2212 hematopoietic stem cells and decreases the risk of clonal evolution","volume":"101","author":"Haneline","year":"2003","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-472X(98)00064-2","article-title":"The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-alpha and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily","volume":"27","author":"Koh","year":"1999","journal-title":"Exp. Hematol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0325","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1182\/blood-2004-03-1094","article-title":"Continuous in vivo infusion of interferon-gamma (IFN-gamma) preferentially reduces myeloid progenitor numbers and enhances engraftment of syngeneic wild-type cells in Fancc\u2212\/\u2212 mice","volume":"104","author":"Li","year":"2004","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0330","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI119836","article-title":"MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups","volume":"100","author":"Li","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0335","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.arcmed.2003.09.009","article-title":"Hematopoietic stem cells in aplastic anemia","volume":"34","author":"Maciejewski","year":"2003","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0340","doi-asserted-by":"crossref","first-page":"55578","DOI":"10.1074\/jbc.M408238200","article-title":"NF-kappa B family proteins participate in multiple steps of hematopoiesis through elimination of reactive oxygen species","volume":"279","author":"Nakata","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcmd.2013.06.005_bb0345","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1093\/emboj\/20.16.4478","article-title":"FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma\/TNF-alpha-mediated cytotoxicity","volume":"20","author":"Pang","year":"2001","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0350","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1182\/blood.V98.5.1392","article-title":"The Fanconi anemia complementation group C gene product: structural evidence of multifunctionality","volume":"98","author":"Pang","year":"2001","journal-title":"Blood"},{"issue":"51","key":"10.1016\/j.bcmd.2013.06.005_bb0355","doi-asserted-by":"crossref","first-page":"49638","DOI":"10.1074\/jbc.M209386200","article-title":"The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC","volume":"277","author":"Pang","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0360","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1182\/blood.V90.3.974","article-title":"Inactivation of the Fanconi anemia group C gene augments interferon-gamma-induced apoptotic responses in hematopoietic cells","volume":"90","author":"Rathbun","year":"1997","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcmd.2013.06.005_bb0365","doi-asserted-by":"crossref","first-page":"4204-4011","DOI":"10.1182\/blood.V96.13.4204","article-title":"Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members","volume":"96","author":"Rathbun","year":"2000","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcmd.2013.06.005_bb0370","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1182\/blood-2006-03-007997","article-title":"Continuous in vivo infusion of interferon-gamma (IFN-gamma) enhances engraftment of syngeneic wild-type cells in Fanca\u2212\/\u2212 and Fancg\u2212\/\u2212 mice","volume":"108","author":"Si","year":"2006","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.bcmd.2013.06.005_bb0375","first-page":"3538","article-title":"Overexpression of the Fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis","volume":"58","author":"Wang","year":"1998","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0380","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1182\/blood.V88.1.49.49","article-title":"Germ cell defects and hematopoietic hypersensitivity to gamma-interferon in mice with a targeted disruption of the Fanconi anemia C gene","volume":"88","author":"Whitney","year":"1996","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0385","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1093\/hmg\/9.12.1805","article-title":"Mice with a targeted disruption of the Fanconi anemia homolog Fanca","volume":"9","author":"Cheng","year":"2000","journal-title":"Hum. Mol. Genet."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0390","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S1471-4914(01)02262-6","article-title":"Disease model: Fanconi anemia","volume":"8","author":"Wong","year":"2002","journal-title":"Trends Mol. Med."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0395","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1182\/blood.V98.12.3435","article-title":"Targeted disruption of the murine Fanconi anemia gene, Fancg\/Xrcc9","volume":"98","author":"Yang","year":"2001","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcmd.2013.06.005_bb0400","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1128\/MCB.20.13.4724-4735.2000","article-title":"The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by gamma interferon and hematopoietic growth factors","volume":"20","author":"Pang","year":"2000","journal-title":"Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0405","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng0496-448","article-title":"Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia","volume":"12","author":"Chen","year":"1996","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0410","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0301-472X(02)00838-X","article-title":"Fanconi anemia group A and C double-mutant mice: functional evidence for a multi-protein Fanconi anemia complex","volume":"30","author":"Noll","year":"2002","journal-title":"Exp. Hematol."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0415","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1182\/blood.V100.6.2032","article-title":"In vitro phenotypic correction of hematopoietic progenitors from Fanconi anemia group A knockout mice","volume":"100","author":"R\u00edo","year":"2002","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0420","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/hmg\/11.3.273","article-title":"Reduced fertility and hypersensitivity to mitomycin C characterize Fancg\/Xrcc9 null mice","volume":"11","author":"Koomen","year":"2002","journal-title":"Hum. Mol. Genet."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0425","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/(SICI)1097-4652(199904)179:1<79::AID-JCP10>3.0.CO;2-O","article-title":"Tumor necrosis factor-alpha and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice","volume":"179","author":"Otsuki","year":"1999","journal-title":"J. Cell. Physiol."},{"issue":"26","key":"10.1016\/j.bcmd.2013.06.005_bb0430","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2009-05-222414","article-title":"TLR8-dependent TNF-(alpha) overexpression in Fanconi anemia group C cells","volume":"114","author":"Vanderwerf","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bcmd.2013.06.005_bb0435","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1182\/blood-2005-05-2096","article-title":"Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1","volume":"106","author":"Nijangi-Cishehsaraei","year":"2005","journal-title":"Blood"},{"issue":"5296","key":"10.1016\/j.bcmd.2013.06.005_bb0440","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1126\/science.275.5296.90","article-title":"Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK\/JNK and p38 signaling pathways","volume":"275","author":"Ichijo","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0445","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0300-9084(00)00359-X","article-title":"Loss of the Fanconi anemia group C protein activity results in an inability to activate caspase-3 after ionizing radiation","volume":"82","author":"Guillouf","year":"2000","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0450","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2141.2006.06432.x","article-title":"Human Fanconi A cells are susceptible to TRAIL-induced apoptosis","volume":"136","author":"Pigullo","year":"2007","journal-title":"Br. J. Haematol."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0455","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0002-9440(10)62277-8","article-title":"Evidence for a role of TNF-related apoptosis-inducing ligand (TRAIL) in the anemia of myelodysplastic syndromes","volume":"166","author":"Campioni","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.bcmd.2013.06.005_bb0460","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/jcb.23161","article-title":"Fanconi anemia D2 protein is an apoptotic target mediated by caspases","volume":"112","author":"Park","year":"2011","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0465","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.cr.7290259","article-title":"Molecular mechanism of TNF signaling and beyond","volume":"15","author":"Liu","year":"2005","journal-title":"Cell. Res."},{"issue":"26","key":"10.1016\/j.bcmd.2013.06.005_bb0470","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199606273342607","article-title":"The tumor necrosis factor ligand and receptor families","volume":"334","author":"Bazzoni","year":"1996","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/nrd3930","article-title":"Clinical targeting of the TNF and TNFR superfamilies","volume":"12","author":"Croft","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0480","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","article-title":"Tumor necrosis factor","volume":"328","author":"Chu","year":"2013","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0485","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/187153009789044347","article-title":"TNF alpha inhibition as treatment modality for certain rheumatologic and gastrointestinal diseases","volume":"9","author":"Wiedmann","year":"2009","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0490","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/BF00207040","article-title":"Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6","volume":"89","author":"Rosselli","year":"1992","journal-title":"Hum. Genet."},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0495","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1161\/01.RES.86.8.906","article-title":"Cyclooxygenase-2 is required for tumor necrosis factor-alpha- and angiotensin II-mediated proliferation of vascular smooth muscle cells","volume":"86","author":"Young","year":"2000","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0500","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1172\/JCI114186","article-title":"Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control","volume":"84","author":"Oster","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0505","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/sj.leu.2400844","article-title":"Overexpression of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma by bone marrow cells from patients with myelodysplastic syndromes","volume":"11","author":"Kitagawa","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0510","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1196\/annals.1378.063","article-title":"Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution","volume":"1091","author":"Aggarwal","year":"2006","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.bcmd.2013.06.005_bb0515","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrd2805","article-title":"Averting inflammation by targeting the cytokine environment","volume":"9","author":"Kopf","year":"2010","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"10","key":"10.1016\/j.bcmd.2013.06.005_bb0520","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","article-title":"Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development","volume":"23","author":"Arnott","year":"2004","journal-title":"Oncogene"},{"issue":"31","key":"10.1016\/j.bcmd.2013.06.005_bb0525","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1038\/sj.onc.1205588","article-title":"Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway","volume":"21","author":"Arnott","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0530","first-page":"445","article-title":"An anti-tumor necrosis factor-alpha antibody inhibits the development of experimental skin tumors","volume":"2","author":"Scott","year":"2003","journal-title":"Mol. Cancer Ther."},{"issue":"27","key":"10.1016\/j.bcmd.2013.06.005_bb0535","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.3748\/wjg.v13.i27.3677","article-title":"Platelet aggregation is affected by nitrosothiols in patients with chronic hepatitis: in vivo and in vitro studies","volume":"13","author":"Federico","year":"2007","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.bcmd.2013.06.005_bb0540","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0962-8924(01)02064-5","article-title":"Signal transduction by tumor necrosis factor and its relatives","volume":"11","author":"Baud","year":"2001","journal-title":"Trends Cell Biol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0550","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1097-2765(03)00399-X","article-title":"Adding facets to TNF signaling. The JNK angle","volume":"12","author":"Liu","year":"2003","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0555","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(04)00166-7","article-title":"Tumor necrosis factor: an apoptosis JuNKie?","volume":"116","author":"Varfolomeev","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0560","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/7410","article-title":"Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB","volume":"5","author":"Wang","year":"1999","journal-title":"Nat. Med."},{"issue":"6861","key":"10.1016\/j.bcmd.2013.06.005_bb0565","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/35104568","article-title":"Inhibition of JNK activation through NF-kappaB target genes","volume":"414","author":"Tang","year":"2001","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0570","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)80391-X","article-title":"Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice","volume":"7","author":"Yeh","year":"1997","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0575","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1074-7613(00)80535-X","article-title":"The death domain kinase RIP mediates the TNF-induced NF-kappaB signal","volume":"8","author":"Kelliher","year":"1998","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0580","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat. Rev. Cancer"},{"issue":"5358","key":"10.1016\/j.bcmd.2013.06.005_bb0585","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.279.5358.1954","article-title":"FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis","volume":"279","author":"Yeh","year":"1998","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0590","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1128\/MCB.23.8.2871-2882.2003","article-title":"c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor","volume":"23","author":"Ventura","year":"2003","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0595","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0092-8674(00)81375-6","article-title":"Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death","volume":"87","author":"Liu","year":"1996","journal-title":"Cell"},{"issue":"5297","key":"10.1016\/j.bcmd.2013.06.005_bb0600","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1126\/science.275.5297.200","article-title":"Activation of SAPK\/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway","volume":"275","author":"Natoli","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0605","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/S1097-2765(03)00203-X","article-title":"JunD mediates survival signaling by the JNK signal transduction pathway","volume":"11","author":"Lamb","year":"2003","journal-title":"Mol. Cell"},{"issue":"15","key":"10.1016\/j.bcmd.2013.06.005_bb0610","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1093\/emboj\/cdg379","article-title":"NF-kappaB inhibits TNF-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death","volume":"22","author":"Sakon","year":"2003","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0615","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S1074-7613(00)80390-8","article-title":"TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival","volume":"7","author":"Lee","year":"1997","journal-title":"Immunity"},{"issue":"17","key":"10.1016\/j.bcmd.2013.06.005_bb0620","doi-asserted-by":"crossref","first-page":"10232","DOI":"10.1074\/jbc.273.17.10232","article-title":"Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha","volume":"273","author":"Roulston","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"23","key":"10.1016\/j.bcmd.2013.06.005_bb0625","doi-asserted-by":"crossref","first-page":"8175","DOI":"10.1128\/MCB.22.23.8175-8183.2002","article-title":"The p65\/RelA subunit of NF-kappaB suppresses the sustained, antiapoptotic activity of Jun kinase induced by tumor necrosis factor","volume":"22","author":"Reuther-Madrid","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"17","key":"10.1016\/j.bcmd.2013.06.005_bb0630","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1074\/jbc.273.17.10362","article-title":"Inhibition of the expression of mitogen-activated protein phosphatase-1 potentiates apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells","volume":"273","author":"Guo","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"6861","key":"10.1016\/j.bcmd.2013.06.005_bb0635","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/35104560","article-title":"Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signaling","volume":"414","author":"De Smaele","year":"2001","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bcmd.2013.06.005_bb0640","doi-asserted-by":"crossref","first-page":"8571","DOI":"10.1128\/MCB.22.24.8571-8579.2002","article-title":"The absence of NF-kappaB-mediated inhibition of c-Jun N-terminal kinase activation contributes to tumor necrosis factor alpha-induced apoptosis","volume":"22","author":"Tang","year":"2002","journal-title":"Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0645","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0092-8674(03)00757-8","article-title":"A JNK-dependent pathway is required for TNFalpha-induced apoptosis","volume":"115","author":"Deng","year":"2003","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0650","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ncb1093","article-title":"Gadd45 beta mediates the NF-kappa B suppression of JNK signaling by targeting MKK7\/JNKK2","volume":"6","author":"Papa","year":"2004","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0655","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1093\/emboj\/cdf306","article-title":"TNF superfamily ligand that triggers the Drosophila JNK pathway","volume":"21","author":"Igaki","year":"2002","journal-title":"EMBO J."},{"issue":"14","key":"10.1016\/j.bcmd.2013.06.005_bb0660","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/S0960-9822(02)00954-5","article-title":"Evolution of TNF signaling mechanisms: JNK-dependent apoptosis triggered by Eiger, the Drosophila homolog of the TNF superfamily","volume":"12","author":"Moreno","year":"2002","journal-title":"Curr. Biol."},{"issue":"31","key":"10.1016\/j.bcmd.2013.06.005_bb0665","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.1038\/sj.onc.1206715","article-title":"Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila","volume":"22","author":"Kauppila","year":"2003","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0670","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood.V85.11.3183.bloodjournal85113183","article-title":"Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro","volume":"85","author":"Maciejewski","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2013.06.005_bb0675","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood.V89.3.957","article-title":"Involvement of Fas-mediated apoptosis in the inhibitory effects of interferon-alpha in chronic myelogenous leukemia","volume":"89","author":"Selleri","year":"1997","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0680","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1182\/blood.V85.12.3367.bloodjournal85123367","article-title":"The treatment of severe acquired aplastic anemia","volume":"85","author":"Young","year":"1995","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bcmd.2013.06.005_bb0685","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.1223004","article-title":"JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species","volume":"18","author":"Ventura","year":"2004","journal-title":"Genes Dev."},{"issue":"5573","key":"10.1016\/j.bcmd.2013.06.005_bb0690","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1126\/science.1071924","article-title":"TNF-R1 signaling: a beautiful pathway","volume":"296","author":"Chen","year":"2002","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0695","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.cellsig.2007.01.020","article-title":"TNF-alpha-induced NF-kappaB\/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway","volume":"19","author":"Jamaluddin","year":"2007","journal-title":"Cell. Signal."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0700","doi-asserted-by":"crossref","first-page":"H1813","DOI":"10.1152\/ajpheart.00036.2004","article-title":"In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure","volume":"287","author":"Moe","year":"2004","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0705","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/1568010054526287","article-title":"Toxicity and roles of reactive oxygen species","volume":"4","author":"Kimura","year":"2005","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"10","key":"10.1016\/j.bcmd.2013.06.005_bb0710","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000055318.09997.1F","article-title":"Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes","volume":"107","author":"Suematsu","year":"2003","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0715","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4049\/jimmunol.138.1.185","article-title":"Interleukin 2 receptors are expressed by alveolar macrophages during pulmonary sarcoidosis and are inducible by lymphokine treatment of normal human lung macrophages, blood monocytes, and monocyte cell lines","volume":"138","author":"Hancock","year":"1987","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0720","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2174\/1568010023344571","article-title":"The role of TNF and its family members in inflammation and cancer: lessons from gene deletion","volume":"1","author":"Aggarwal","year":"2002","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0725","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.cdd.4401189","article-title":"Tumor necrosis factor signaling","volume":"10","author":"Wajant","year":"2003","journal-title":"Cell Death Differ."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0730","first-page":"889","article-title":"TNF-alpha induced DNA damage in primary murine hepatocytes","volume":"12","author":"Wheelhouse","year":"2003","journal-title":"Int. J. Mol. Med."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0735","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1080\/1071576021000038531","article-title":"Oxidative stress, inflammation, and diabetic vasculopathies: the role of alpha tocopherol therapy","volume":"36","author":"Jialal","year":"2002","journal-title":"Free Radic. Res."},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0740","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1006\/cyto.1999.0638","article-title":"Induction of oxidative DNA damage in u937 cells by TNF or anti-Fas stimulation","volume":"12","author":"Nathan","year":"2000","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0745","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/(SICI)1097-4652(199801)174:1<27::AID-JCP4>3.0.CO;2-I","article-title":"Overexpression of HSP25 reduces the level of TNF alpha-induced oxidative DNA damage biomarker, 8-hydroxy-2\u2032-deoxyguanosine, in L929 cells","volume":"174","author":"Park","year":"1998","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0750","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hep.20755","article-title":"Oxidative mitochondrial DNA damage and deletion in hepatocytes of rejecting liver allografts in rats: role of TNF-alpha","volume":"42","author":"Nagakawa","year":"2005","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0755","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1046-2023(02)00209-8","article-title":"Measurement of UVB-induced DNA damage and its consequences in models of immunosuppression","volume":"28","author":"Yarosh","year":"2002","journal-title":"Methods"},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0760","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1172\/JCI0215548","article-title":"Transcriptional control of viral gene therapy by cisplatin","volume":"110","author":"Park","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0765","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/09553000600568002","article-title":"Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation","volume":"81","author":"Calveley","year":"2005","journal-title":"Int. J. Radiat. Biol."},{"issue":"37","key":"10.1016\/j.bcmd.2013.06.005_bb0770","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1038\/sj.onc.1206701","article-title":"MAPK pathways in radiation responses","volume":"22","author":"Dent","year":"2003","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0775","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1101\/gad.1062403","article-title":"The death domain kinase RIP has an essential role in DNA damage-induced NF-kappa B activation","volume":"17","author":"Hur","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0780","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/rp.58.1.283","article-title":"Regulation of hematopoietic stem cell self-renewal","volume":"58","author":"Reya","year":"2003","journal-title":"Recent Prog. Horm. Res."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0785","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4049\/jimmunol.180.1.49","article-title":"TNF-alpha is critical to facilitate hemopoietic stem cell engraftment and function","volume":"180","author":"Rezzoug","year":"2008","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0790","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1182\/blood.V78.5.1237.1237","article-title":"Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil","volume":"78","author":"Harrison","year":"1991","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0800","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI67146","article-title":"Defective telomere elongation and hematopoiesis from telomerase-mutant aplastic anemia iPSCs","volume":"123","author":"Winkler","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0805","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/jcp.20235","article-title":"Involvement of the tumor necrosis factor (TNF)\/TNF receptor system in leukemic cell apoptosis induced by histone deacetylase inhibitor depsipeptide (FK228)","volume":"203","author":"Sutheesophon","year":"2005","journal-title":"J. Cell. Physiol."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0810","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/emm.2007.14","article-title":"TNF-alpha upregulates PTEN via NF-kappaB signaling pathways in human leukemic cells","volume":"39","author":"Lee","year":"2007","journal-title":"Exp. Mol. Med."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0815","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.leu.2403359","article-title":"TNF-alpha receptor 1 expression on acute myeloid leukemic blasts predicts differentiation into leukemic dendritic cells","volume":"18","author":"Houtenbos","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0820","first-page":"693","article-title":"The role of CD154 in haematopoietic development","volume":"104","author":"Seijkens","year":"2010","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0825","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/jcb.22549","article-title":"TRAIL\/TRAIL-R in hematologic malignancies","volume":"110","author":"Testa","year":"2010","journal-title":"J. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0830","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1600-0609.1996.tb01364.x","article-title":"Decreased IL-1 beta and TNF alpha secretion in long-term bone marrow culture supernatant from Fanconi's anaemia patients","volume":"57","author":"de Cremoux","year":"1996","journal-title":"Eur. J. Haematol."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0835","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2141.1993.tb04691.x","article-title":"The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias","volume":"83","author":"Stark","year":"1993","journal-title":"Br. J. Haematol."},{"issue":"13","key":"10.1016\/j.bcmd.2013.06.005_bb0840","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1182\/blood-2005-05-2096","article-title":"Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1","volume":"106","author":"Bijangi-Cishehsaraei","year":"2005","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.bcmd.2013.06.005_bb0845","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1182\/blood-2004-06-2483","article-title":"Ex vivo culture of Fancc\u2212\/\u2212 stem\/progenitor cells predisposes cells to undergo apoptosis, and surviving stem\/progenitor cells display cytogenetic abnormalities and an increased risk of malignancy","volume":"105","author":"Li","year":"2005","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0850","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1172\/JCI31772","article-title":"TNF-alpha induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells","volume":"117","author":"Li","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0855","doi-asserted-by":"crossref","first-page":"e23324","DOI":"10.1371\/journal.pone.0023324","article-title":"Direct inhibition of TNF-\u03b1 promoter activity by Fanconi anemia protein FANCD2","volume":"6","author":"Matsushita","year":"2011","journal-title":"PLoS One"},{"issue":"1\u20132","key":"10.1016\/j.bcmd.2013.06.005_bb0860","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/BC-2011-227","article-title":"Oxidative stress in Fanconi anaemia: from cells and molecules towards prospects in clinical management","volume":"393","author":"Pagano","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0865","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1242\/jcs.003152","article-title":"Inflammatory ROS promote and cooperate with the Fanconi anemia mutation for hematopoietic senescence","volume":"120","author":"Zhang","year":"2007","journal-title":"J. Cell Sci."},{"issue":"18","key":"10.1016\/j.bcmd.2013.06.005_bb0870","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2011-09-381970","article-title":"The FA pathway counteracts oxidative stress through selective protection of antioxidant defense gene promoters","volume":"119","author":"Du","year":"2012","journal-title":"Blood"},{"issue":"Suppl. 4","key":"10.1016\/j.bcmd.2013.06.005_bb0875","doi-asserted-by":"crossref","first-page":"iv2","DOI":"10.1136\/ard.2005.044941","article-title":"Updated consensus statement on biological agents, specifically tumour necrosis factor alpha (TNF{alpha}) blocking agents and interleukin-1 receptor antagonist (IL-1ra), for the treatment of rheumatic diseases","volume":"64","author":"Furst","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0880","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/978-0-387-89520-8_12","article-title":"Targeting CD30\/CD30L in oncology and autoimmune and inflammatory diseases","volume":"647","author":"Oflazoglu","year":"2009","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0885","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.med.50.1.291","article-title":"Immunologic therapy of multiple sclerosis","volume":"50","author":"Arnason","year":"1999","journal-title":"Annu. Rev. Med."},{"issue":"4","key":"10.1016\/j.bcmd.2013.06.005_bb0890","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1365-2036.2012.05189.x","article-title":"Review article: non-malignant haematological complications of anti-tumour necrosis factor alpha therapy","volume":"36","author":"Bessissow","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.bcmd.2013.06.005_bb0895","first-page":"S1043","article-title":"Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability","author":"Harvey","year":"2013","journal-title":"Cytokine"},{"issue":"5\u20136","key":"10.1016\/j.bcmd.2013.06.005_bb0900","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2011.09.004","article-title":"Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1","volume":"22","author":"Van Hauwermeiren","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"issue":"15","key":"10.1016\/j.bcmd.2013.06.005_bb0905","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","article-title":"A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group","volume":"337","author":"Targan","year":"1997","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.bcmd.2013.06.005_bb0910","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/labinvest.2011.160","article-title":"The anti-TNF-\u03b1 antibody infliximab indirectly regulates PECAM-1 gene expression in two models of in vitro blood cell activation","volume":"92","author":"Moriconi","year":"2012","journal-title":"Lab. Invest."},{"issue":"23","key":"10.1016\/j.bcmd.2013.06.005_bb0915","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1056\/NEJMoa050516","article-title":"Infliximab for induction and maintenance therapy for ulcerative colitis","volume":"353","author":"Rutgeerts","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.bcmd.2013.06.005_bb0920","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2141.2012.09250.x","article-title":"Etanercept treatment in Fanconi anaemia; combined US and Italian experience","volume":"158","author":"Mehta","year":"2012","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/j.bcmd.2013.06.005_bb0925","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.crohns.2009.12.001","article-title":"A decade of infliximab: the Austrian evidence based consensus on the safe use of infliximab in inflammatory bowel disease","volume":"4","author":"Miehsler","year":"2010","journal-title":"J. Crohns Colitis"},{"issue":"12","key":"10.1016\/j.bcmd.2013.06.005_bb0930","first-page":"2563","article-title":"Adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)","volume":"30","author":"Furst","year":"2003","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.bcmd.2013.06.005_bb0935","first-page":"2315","article-title":"Do the clinical responses and complications following etanercept or infliximab therapy predict similar outcomes with the other tumor necrosis factor-alpha antagonists in patients with rheumatoid arthritis?","volume":"30","author":"Ang","year":"2003","journal-title":"J. Rheumatol."},{"issue":"8","key":"10.1016\/j.bcmd.2013.06.005_bb0940","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1002\/ibd.21217","article-title":"Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease","volume":"16","author":"O'Connor","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"5","key":"10.1016\/j.bcmd.2013.06.005_bb0945","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/art.21869","article-title":"Solid malignancies among patients in the Wegener's granulomatosis etanercept trial","volume":"54","author":"Stone","year":"2006","journal-title":"Arthritis Rheum."},{"issue":"18","key":"10.1016\/j.bcmd.2013.06.005_bb0950","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2174\/092986706777935294","article-title":"The molecular biology of TRAIL-mediated signaling and its potential therapeutic exploitation in hematopoietic malignancies","volume":"13","author":"Boehrer","year":"2006","journal-title":"Curr. Med. Chem."},{"issue":"1","key":"10.1016\/j.bcmd.2013.06.005_bb0955","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jmg.40.1.1","article-title":"Fanconi anaemia","volume":"40","author":"Tischkowitz","year":"2003","journal-title":"J. Med. Genet."},{"issue":"7","key":"10.1016\/j.bcmd.2013.06.005_bb0960","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1182\/blood-2003-08-2915","article-title":"Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes","volume":"103","author":"Levitus","year":"2004","journal-title":"Blood"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979613001514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:29:52Z","timestamp":1761049792000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979613001514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":190,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S1079979613001514"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.06.005","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TNF-\u03b1 signaling in Fanconi anemia","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2013.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}